Track the 파마리서치바이오 stock price and the full directors' dealings record of the company, a listed issuer based in South Korea. Shares trade on the KR market, under the oversight of DART (FSS). Operating in the Health Care sector, 파마리서치바이오 has published 11 insider filings. Market capitalisation: €128.4bn. The latest transaction was reported on 4 March 2026 (Sale). Among the most active insiders: 신한캐피탈. Every trade is openly available.
11
Insider Decl.
n/a
Thresholds
n/a
3 ops.
Buy Volume
n/a
7 ops.
Sell Volume
Fundamental score
Ranked 4,723 of 29,156 companies
69.2
score / 100
Value
62
Quality
77
FCF yld-0.9%
Earn yld9.6%
EV/EBITDA9.4x
ROE·
Gross mgn70%
Net mgn40%
Debt/EBITDA2.0x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
파마리서치바이오 operates in the health and pharmaceutical sector, listed on the XKRX market. The company focuses on the research and development of biopharmaceutical solutions.